Host population bottlenecks decrease microbiome diversity. by Michael Ørsted (5926028)

Resveratrol decreased acetylated RelA/p65. A. by Xiaoxia Zhu (301292)

Linear decrease of delta power (1.1–5.0 Hz) across the first three sleep cycles in the cortical, hippocampal and scalp recordings. by Fabio Moroni (34208)

Effect of cilostazol on the serum ALT (A), AST (B) levels in rats with TAA-induced liver fibrosis. by Sally A. El Awdan (710176)

Effect of cilostazol on liver α-SMA (A) and COL-1 (B) in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

S1 Data - by Win Win Pyone (20396432)

“…Diuron exhibits higher phytotoxicity in sand compared to loamy sand, with ED₅₀ values (which is the dose at which diuron causes a 50% decrease in plant growth) of 0.03 mg kg^-1 and 0.07 mg kg^-1 for canola shoot biomass inhibition and 0.01 mg kg^-1 and 0.06 mg kg^-1 for root dry weight reduction, respectively. …”

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

Fig 1 - by Win Win Pyone (20396432)

Dexmedetomidine in combination with morphine improves postoperative analgesia and sleep quality in elderly patients after open abdominal surgery: A pilot randomized control trial by Huai-Jin Li (5628722)

“…</p><p>Results</p><p>The 72-hour morphine consumption was lower in the DEX group than in the CTRL group (median 39.0 mg [interquartile range 37.3, 41.0] in the DEX group vs. 49.0 mg [45.5, 50.0] in the CTRL group; median difference -9.0 mg [95% CI -10.0, -6.0], P < 0.001). …”

Decreased neutrophil and monocyte antigen expression in the paws of anti-S100A9-treated mice. by Annabelle Cesaro (112070)

Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

Subjects:

Pairwise comparisons of hormonal results for DMPA-IM vs NET-EN expressed as mean percentage differences (95% CI) (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (pmol/L) outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

Total testosterone (nmol/L), SHBG (nmol/L) and free testosterone (nmol/L), outcomes at baseline and 25 weeks (mITT analysis). by Chanel Avenant (409756)

Subjects:

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

NLS-tagged RIG-I stimulates immune responses and decreased viral RNA levels in HCV-infected cells. by Christopher J. Neufeldt (478659)

Sensitivity analysis of 50:50 model. by Rachael Miller Neilan (10678614)

“…<p>A sensitivity analysis was conducted on the 50:50 model with constant 120 pA current to determine the sensitivity of pain output to select model parameters before injury (t = 10), during injury (t = 105), and after injury (t = 240). …”

Dose response of airways to Methacholine shows a decreased contractility in <i>GSTCD</i>^-/- mouse lungs following LPS treatment. by Bo Liu (127343)

Renin–angiotensin–aldosterone system inhibition with losartan significantly inhibited transforming growth factor-β1/Smads pathway and decreased Snail expression in vitro. by Chiao-Yin Sun (174213)

“…<p>A: ELISA analysis showed that losartan (1, 10, and 100 uM) significantly decreased the transforming growth factor-β1 concentration in the culture medium of PKSV cells treated with indoxyl sulfate (IS) (50 mg/L) and <i>p</i>-cresol sulfate (PCS) (50 mg/L). …”

The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

“…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”